论文部分内容阅读
AIM To evaluate the pharmacodynamics of compounds in clinical development for nonalcoholic steatohepatitis(NASH)in obese mouse models of biopsy-confirmed NASH.METHODS Male wild-type C57BL/6J mice(DIO-NASH)and Lepob/ob(ob/ob-NASH)mice were fed a diet high